ImmunoCellular Therapeutics, Ltd. (AMEX:IMUC) is seeking acquisitions. Anthony Gringeri, President and Chief Executive Officer of ImmunoCellular, said, “We plan to continue to evaluate opportunities to license or acquire new technology that can further complement and expand our immunotherapy platform.”